Robert Bruce's PFE Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 271,900 shares of Pfizer Inc. (PFE) worth $6.77 M, representing 2.10% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Robert Bruce has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2018, adding 100,000 shares. Largest reduction occurred in Q4 2023, reducing 251,000 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Robert Bruce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +432,000 | Add 0.00% | 432,000 | $28.00 |
| Q4 2013 | +20,000 | Add 4.63% | 452,000 | $30.63 |
| Q4 2014 | +3,332 | Add 0.74% | 455,332 | $31.15 |
| Q1 2018 | +100,000 | Add 21.96% | 555,332 | $35.49 |
| Q2 2019 | -46,500 | Reduce 8.37% | 508,832 | $43.32 |
| Q3 2019 | +9,000 | Add 1.77% | 517,832 | $35.93 |
| Q1 2021 | +49,800 | Add 9.62% | 567,632 | $36.23 |
| Q2 2021 | -1,000 | Reduce 0.18% | 566,632 | $39.16 |
| Q3 2021 | -21,932 | Reduce 3.87% | 544,700 | $43.01 |
| Q4 2021 | -1,000 | Reduce 0.18% | 543,700 | $59.05 |
| Q1 2022 | -1,000 | Reduce 0.18% | 542,700 | $51.77 |
| Q1 2023 | -4,074 | Reduce 0.75% | 538,626 | $40.80 |
| Q3 2023 | -19,126 | Reduce 3.55% | 519,500 | $33.17 |
| Q4 2023 | -251,000 | Reduce 48.32% | 268,500 | $28.79 |
| Q2 2024 | +7,900 | Add 2.94% | 276,400 | $27.98 |
| Q4 2024 | -4,500 | Reduce 1.63% | 271,900 | $26.53 |
Robert Bruce's Pfizer Investment FAQs
Robert Bruce first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 432,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held Pfizer Inc. (PFE) for 51 quarters since Q2 2013.
Robert Bruce's largest addition to Pfizer Inc. (PFE) was in Q2 2013, adding 432,000 shares worth $12.1 M.
According to the latest 13F filing for Q4 2025, Robert Bruce's firm, Bruce & Co., Inc., owns 271,900 shares of Pfizer Inc. (PFE), valued at approximately $6.77 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 2.10% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Bruce's peak holding in Pfizer Inc. (PFE) was 567,632 shares, as reported at the end of Q1 2021.